ABSTRACT
Long-term photophobia in children that has no obvious cause is uncommon and presents a diagnostic dilemma. It may produce significant discomfort and result in social isolation and school absence. We present the case of a 5-year-old boy who presented with chronic photophobia due to interstitial keratitis that was the result of Lyme disease.
Subject(s)
Keratitis , Lyme Disease , Child , Child, Preschool , Humans , Keratitis/diagnosis , Lyme Disease/complications , Lyme Disease/diagnosis , Lyme Disease/drug therapy , Male , Photophobia/diagnosis , Photophobia/etiologySubject(s)
Diplopia/therapy , Disease Management , Eyeglasses , Vision, Binocular/physiology , Diplopia/physiopathology , HumansSubject(s)
Esotropia/therapy , Eyeglasses , Aged , Diagnosis, Differential , Diplopia/etiology , Female , HumansSubject(s)
Ocular Motility Disorders/surgery , Oculomotor Muscles/surgery , Ophthalmologic Surgical Procedures/methods , Surgical Wound Dehiscence/prevention & control , Suture Techniques , Sutures , Wound Healing/physiology , Collagen/metabolism , Cytokines/metabolism , Humans , Surgical Wound Dehiscence/metabolism , Surgical Wound Dehiscence/pathologySubject(s)
Abducens Nerve Diseases/therapy , Abducens Nerve Diseases/complications , Abducens Nerve Diseases/diagnosis , Diplopia/etiology , Diplopia/therapy , Esotropia/etiology , Esotropia/therapy , Eyeglasses , Humans , Oculomotor Muscles/surgery , Ophthalmologic Surgical Procedures , Sensory Deprivation , Vision, BinocularABSTRACT
PURPOSE: Atropine 1% has been used to slow the progression of myopia; however, it has not gained worldwide clinical acceptance because it results in clinically significant pupillary mydriasis and accommodative paralysis. Lower concentrations of atropine (0.5 to 0.01%) have been reported to be associated with fewer symptoms, while still controlling myopia. It is the purpose of this study to find the highest concentration of atropine that does not result in significant symptoms from pupillary dilation and accommodative paralysis. METHODS: A 3 × 3 phase I clinical trial paradigm was used in 12 subjects, to determine the maximum dosage of atropine which could be prescribed without creating symptoms or clinical signs of insufficient accommodation or excessive pupillary dilation. Accommodation was measured by pushouts and pupillary dilation by photography. Prior to this study, we established the following criteria for comfort: 5D or more of residual amplitude of accommodation, less than or equal to a 3 mm pupillary difference between the eyes, and a report of minimal symptoms of near vision blur or outside photophobia. RESULTS: Our results indicate that atropine 0.02% is the highest concentration that did not result in clinical symptoms and findings associated with higher dosages. Mean pupillary dilation was 3 mm, and mean accommodative amplitude was 8 diopters with this concentration. Further, reduction of the concentration of atropine from 0.02 to 0.01% did not seem to result in a decrease in clinical signs or symptoms associated with atropine. CONCLUSIONS: Atropine 0.02% is the highest concentration that does not produce significant clinical symptoms from accommodation paresis or pupillary dilation. This would be an appropriate starting point in evaluating a low dosage of atropine to slow myopic progression.
Subject(s)
Accommodation, Ocular/drug effects , Atropine/administration & dosage , Mydriatics/administration & dosage , Pupil/drug effects , Adolescent , Atropine/adverse effects , Child , Female , Humans , Male , Maximum Tolerated Dose , Mydriasis/chemically induced , Mydriatics/adverse effects , Myopia/drug therapy , Pupil Disorders/chemically inducedABSTRACT
PURPOSE: The aim of this study was to look for the response to strabismus images in the limbic network (amygdala, hippocampus, parahippocampus) of healthy volunteers and to compare it with their reaction to viewing normal eyes. DESIGN: Prospective, observational study. PARTICIPANTS: Thirty-one healthy volunteers underwent functional magnetic resonance imaging (fMRI). METHODS: Functional magnetic resonance imaging data and blood oxygen level-dependent signal changes were analyzed using the BrainVoyager QX software package (Brain Innovation, Maastricht, The Netherlands). MAIN OUTCOME MEASURES: Responses to viewing strabismus images were compared with those observed while viewing normal eye images. RESULTS: Strabismus images led to significant activation of the amygdala, hippocampus, parahippocampal, and fusiform gyri in 30 of 31 subjects compared with normal eye images, indicating a negative emotional response. CONCLUSIONS: These fMRI results confirm that strabismus influences organically not only the patient with nonparallel eyes but also observers. Treatment of strabismus therefore changes the interpersonal dynamic for patients with strabismus on a demonstrable organic basis. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Subject(s)
Amygdala/physiology , Magnetic Resonance Imaging/methods , Strabismus , Visual Perception/physiology , Adult , Aged , Female , Hippocampus/physiology , Humans , Male , Middle Aged , Photic Stimulation/methods , Prospective Studies , Strabismus/psychology , Surveys and QuestionnairesABSTRACT
Congenital Horner syndrome is a rare disorder that accounts for less than 5% of all cases of Horner syndrome. Like Horner syndrome in general, it consists primarily of ptosis, miosis, and anhidrosis. Congenital Horner syndrome may manifest some special features such as iris heterochromia since the sympathetic nervous system is an essential component for the development and maintenance of eye color. We present 3 cases of unilateral straight hair in association with congenital Horner syndrome in which the patients had straight hair ipsilateral to the Horner syndrome, whereas on the contralateral side, it was curly, and we discuss possible mechanisms for this phenomenon.
Subject(s)
Horner Syndrome/congenital , Iris Diseases/etiology , Pigmentation Disorders/etiology , Child, Preschool , Diagnosis, Differential , Eye Color , Horner Syndrome/complications , Horner Syndrome/diagnosis , Humans , Infant , Infant, Newborn , Iris Diseases/diagnosis , Male , Pigmentation Disorders/diagnosisABSTRACT
We report iridocorneal endothelial syndrome in a male who presented at the age of 16 years with a 3-year history of complaints of blurred vision, altered pupillary shape, and monocular diplopia OD. The examination was notable for unilateral effacement of the iris architecture, stretch holes, corectopia, and localized ectropion uveae. Intraocular pressures were 41 mm Hg OD and 10 mm Hg OS. Gonioscopy revealed intermittent areas of broad synechiae anterior to Schwalbe's line alternating with a clinically normal appearance. The left eye and angle were unremarkable. Specular microscopy confirmed the presence of unilateral endothelial pleomorphism and polymegathism. To our knowledge, this is the earliest reported case of iridocorneal endothelial syndrome in a young man.
